Gaithersburg, MD, United States of America

Qing Zhu

This inventor holds 16 USPTO granted patents and 2 published patent applications and 3 EPO patents, primarily in Vaccine Development. Top assignees: Medimmune Limited, Humabs Biomed Sa, Other. Active years: 2004-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qing Zhu. Retrieved from https://idiyas.com/inventor/qing-zhu-7z4mcwu4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 2)

% Patents Active = 93.8

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 6.0

ph-index = 4

Forward Citations = 45(Granted Patents)

Location History:

Mansfield Center, CT (US) (2004)
Rockville, MD (US) (2016)
Gaithersburg, MD (US) (2014 - 2024)

Company Filing History:

3 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 2004-2025

Loading Chart...

Areas of Expertise:

Neutralizing Antibodies

Influenza A

Influenza B

Binding Molecules

Vaccine Production

Respiratory Syncytial Virus

Optical Tomography

Rotary Mirror Array

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12492240 - NEUTRALIZING ANTI-INFLUENZA A ANTIBODIES AND USES THEREOF (2025-12-09),

2. 12325740 - Neutralizing anti-influenza B antibodies and uses thereof (2025-06-10),

3. 11932682 - Neutralizing anti-influenza A antibodies and uses thereof (2024-03-19),

4. 11926657 - Neutralizing anti-influenza binding molecules and uses thereof (2024-03-12),

5. 11787853 - Neutralizing anti-influenza b antibodies and uses thereof (2023-10-17),

6. 11524993 - Neutralizing anti-influenza binding molecules and uses thereof (2022-12-13),

7. 11186627 - Neutralizing anti-influenza A antibodies and uses thereof (2021-11-30),

8. 11174304 - Neutralizing anti-influenza B antibodies and uses thereof (2021-11-16),

9. 10882897 - Neutralizing anti-influenza binding molecules and uses thereof (2021-01-05),

10. 10519221 - Neutralizing anti-influenza B antibodies and uses thereof (2019-12-31),

11. 10494419 - Neutralizing anti-influenza A antibodies and uses thereof (2019-12-03),

12. 10442854 - Neutralizing anti-influenza binding molecules and uses thereof (2019-10-15),

13. 10294292 - Neutralizing anti-influenza B antibodies and uses thereof (2019-05-21),

14. 9499590 - Antibodies against and methods for producing vaccines for respiratory syncytial virus (2016-11-22),

15. 8852608 - Antibodies against and methods for producing vaccines for respiratory syncytial virus (2014-10-07),

Title: The Innovative Contributions of Qing Zhu

Introduction

Qing Zhu is a prominent inventor based in Gaithersburg, MD, known for his significant contributions to the field of biotechnology. With a total of 15 patents to his name, he has made remarkable advancements in the development of antibodies targeting influenza viruses. His work has the potential to impact public health by providing new avenues for treatment and prevention.

Latest Patents

Among his latest patents, one notable invention is focused on neutralizing anti-influenza B antibodies and their uses. This invention relates to antibodies and antigen binding fragments that can bind to the hemagglutinin of the influenza B virus, effectively neutralizing the virus in two distinct phylogenetic lineages. Specifically, the antibody is capable of targeting both the Yamagata and Victoria lineages of the influenza B virus. Another significant patent involves neutralizing anti-influenza A antibodies, which are designed to bind to the hemagglutinin of the influenza A virus. This invention aims to neutralize at least one group 1 subtype and one group 2 subtype of the influenza A virus, showcasing the breadth of his research.

Career Highlights

Qing Zhu has worked with notable companies in the biotechnology sector, including MedImmune Limited and Humabs Biomed SA. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Throughout his career, Qing Zhu has collaborated with talented individuals such as Nicole Kallewaard-LeLay and Josephine Mary McAuliffe. These partnerships have fostered innovation and have been instrumental in advancing his research endeavors.

Conclusion

Qing Zhu's work exemplifies the spirit of innovation in biotechnology, particularly in the fight against influenza viruses. His patents and collaborations highlight his commitment to improving public health through scientific advancements.

Profile summary based on public USPTO records.